Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granules + Capecitabine in Unresectable Pancreatic Cancer
NCT06387368Phase 4Not yet recruiting
- Sponsor
- Xi'an Jiaotong University
- Start
- May 2024
- Primary completion
- Mar 2028
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of huaier granule in pancreatic adenocarcinoma (PDAC), sponsored by Xi'an Jiaotong University. Planned start May 2024; status: not yet recruiting.
02
Drugs
huaier granule
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT06387368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387368.